Hercules Capital Inc

Hercules Capital Inc(HTGC)股票分析

$16.370

-0.285 (-1.74%)收盤時

Loading chart…
最高
16.685
開盤
16.670
成交量加權均價
16.45
成交量
878.35K
市值
3.29B
最低
16.290
成交金額
14.45M
企業價值/稅息折舊攤銷前利潤(TTM)
10.45

Hercules Capital, Inc. is a specialty finance company. The Company is focused on providing senior secured loans to venture capital-backed and institutional-backed companies in a variety of technology and life sciences industries. It is structured as an internally managed, non-diversified, closed-end investment company. Its business objectives are to increase its net income, net investment income, and net asset value, through its investments in primarily structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It invests in a range of companies active in the technology industry sub-sectors characterized by products or services that require advanced technologies, including computer software and hardware, networking systems, semiconductors, telecommunications equipment and media, semiconductor capital equipment, information technology infrastructure, and others.

AI 分析 of Hercules Capital Inc (HTGC)

持有

Hercules Capital is currently priced at $16.51, with a forward P/E ratio of 8.61, indicating it may be undervalued compared to its earnings potential. However, the RSI is at 34.17, suggesting the stock is oversold and may continue to face downward pressure in the short term. The main risk is the recent decline in net income, which fell to $41.66 million in Q1 2026, down from $61.83 million in Q4 2025, indicating potential volatility in earnings.

分析師評級(11)

上檔空間 +22.42%
買進
7 買進
4 持有
0 賣出
目前: 16.37
最低
18.00
平均
20.04
最高
24.00

UBS

2026-09-01

目標價

—

買進

Ladenburg

2026-07-31

目標價

$20

買進

UBS

2026-05-18

目標價

$15

中性

Ladenburg

2026-05-06

目標價

$21

買進

Piper Sandler

2026-05-06

目標價

$17

中性

估值指標

Hercules Capital Inc(HTGC)目前預期本益比為 8.61,5 年平均預期本益比為 9.16。

預期本益比

合理
5 年均值 P/E
9.16
目前P/E
8.61
高估
10.68
低估
7.64

預期 EV/EBITDA

嚴重高估
5 年均值 EV/EBITDA
1.80
目前EV/EBITDA
10.45
高估
5.97
低估
-2.37

預期股價營收比

合理
5 年均值 P/S
5.42
目前P/S
5.00
高估
6.24
低估
4.60

Alphio AI 對 HTGC 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%HTGC

$22.20

情境價格

基

基準

基準 · 50%HTGC

$20.63

情境價格

悲

悲觀

悲觀 · 25%HTGC

$20.43

情境價格

持有 HTGC 的大戶

A

Ares Management LLC

+ 持有HTGC

-3.44%

3個月報酬率

事件時間軸

2026-10-06 (ET)

16:30:00

Rocket Pharmaceuticals Enters $150 Million Credit Facility with Hercules Capital

2026-09-29 (ET)

07:30:00

NorthStar Medical Technologies Signs Up to $185M Growth Capital Facility with Hercules Capital

2026-07-30 (ET)

16:30:00

Hercules Capital Reports Q2 NII of 50c, Beating Consensus of 48c

2026-06-03 (ET)

07:10:00

Perk Closes $300M Private Credit Facility

2026-05-15 (ET)

08:50:00

Significant Increases in Borrow Rates for Liquid Options

資訊

HTGC 常見問題 —— 由 Alphio AI 解答

Hercules Capital, Inc. is a specialty finance company. The Company is focused on providing senior secured loans to venture capital-backed and institutional-backed companies in a variety of technology and life sciences industries. It is structured as an internally managed, non-diversified, closed-end investment company. Its business objectives are to increase its net income, net investment income, and net asset value, through its investments in primarily structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It invests in a range of companies active in the technology industry sub-sectors characterized by products or services that require advanced technologies, including computer software and hardware, networking systems, semiconductors, telecommunications equipment and media, semiconductor capital equipment, information technology infrastructure, and others. It operates in the Financials sector.

Hercules Capital is currently priced at $16.51, with a forward P/E ratio of 8.61, indicating it may be undervalued compared to its earnings potential. However, the RSI is at 34.17, suggesting the stock is oversold and may continue to face downward pressure in the short term. The main risk is the recent decline in net income, which fell to $41.66 million in Q1 2026, down from $61.83 million in Q4 2025, indicating potential volatility in earnings.

11 analysts cover HTGC: 7 rate it Buy, 4 Hold and 0 Sell. The average price target is 20.04.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易